牛津团队:基于新冠疫情教训呼吁对接触追踪App进行"和平时期的重大投资"
Researchers urge significant 'peacetime' investment in contact tracing apps and digital public health tools
牛津大学Martin School团队发表白皮书,呼吁各国政府在和平时期加大对蓝牙接触追踪App等数字公共卫生工具的投资。新冠期间数字接触追踪App已在至少90个国家部署、全球估计有6亿用户,但许多国家仅在首波疫情后才部署,错失最大化影响力时机。团队提出三大要求:第一天准备就绪、确保公平与公众信任、整合公卫工具箱。
Drawing on lessons from the COVID-19 pandemic, university researchers have detailed how public health agencies across the world can be better prepared for the next epidemic through effective deployment of Bluetooth contact tracing apps and related digital public health tools.
In a white paper published on the Zenodo repository by the Oxford Martin School Programme on Digital Pandemic Preparedness, academics describe how digital contact tracing tools offered significant potential in the global battle against COVID-19, but that lack of preparation and investment led to delayed deployments and missed opportunities. While Bluetooth-based contact tracing apps were rapidly developed, issues around public trust, privacy, integration, equity and knowledge sharing took longer to solve and limited their impact.
Professor Christophe Fraser is Moh Family Foundation professor of infectious disease epidemiology at the Pandemic Sciences Institute, University of Oxford, and leads the program. He said, "At the start of the COVID-19 pandemic, many countries discovered that they were underprepared and were forced into improvised responses. In particular, countries with less recent experience of large-scale infectious disease emergencies had typically underinvested in working out how to act early and quickly to interrupt transmission, and how to enhance traditional, proven public health measures like contact tracing to use the latest technology and keep pace with modern life.
"We are calling on governments and public health agencies across the globe to ensure that digital tools such as Bluetooth contact tracing apps are ready to support outbreak response from the first days of the next pandemic. Digital tools can make a substantial contribution to epidemic control, but most countries remain unprepared to deploy and govern these tools effectively. While refining the technology is a core part of the solution, there needs to be greater focus on building ethical, trusted and interoperable digital public health infrastructure in advance of the next outbreak."
The white paper describes how digital contact tracing apps were deployed in at least 90 countries during COVID-19, with an estimated 600 million users worldwide. However, there were vast differences in how the apps were received. In some countries there was low uptake and the apps had no measurable impact on the epidemic. Other countries saw record-breaking uptake, strong engagement and correspondingly large epidemiological impacts.
Professor Michael Parker, director of the Ethox Centre at Oxford Population Health, said, "It is clear that well-designed digital tools have the potential to make a significant contribution to pandemic preparedness and response. That is, to saving lives, reducing suffering and enabling more informed, less intrusive public health interventions. However, these important benefits will only be achievable if the development and deployment of digital tools is equitable and deserving of well-founded public trust and confidence.
"Evidence suggests that the uptake of digital tools depends on perceived trustworthiness of relevant institutions and legitimacy of decision-making processes. People's willingness to comply with such interventions, such as self-isolating or taking a test on the recommendation of an app notification, depended on trust but also on practical considerations: for many individuals, the economic and social costs of self-isolation were prohibitive. Together these findings suggest the importance of embedding research on ethics and social and behavioral science into pandemic preparedness planning and policy development."
The paper discusses the interdependence of elements of the public health 'toolkit,' particularly the natural dependence of contact tracing on diagnostic testing. A key benefit of digital contact tracing is that it can easily scale up to meet population demand, whereas laboratory tests have natural limits on daily capacity and turnaround times. Symptom-based alerts and rapid home tests can play a role in supporting the case-finding system, and a robust public health response would be adaptable to rapidly changing intervention options and epidemic dynamics.
Delays to app deployments, which limited their ability to support the pre-vaccine phase of the pandemic, are also highlighted by the paper as an area for improvement.
Dr. Michelle Kendall, senior researcher in infectious disease epidemiology at the Pandemic Sciences Institute, and research fellow and impact lead on the Oxford Martin School Programme for Digital Pandemic Preparedness, led the writing of the paper. She said, "Where available, vaccines and treatments are the most effective public health measures for sustained disease control. However, they take time and money to develop, manufacture, transport, test, license and administer.
"In countries where digital contact tracing apps were effective, they had a considerable impact on reducing transmissions, hospitalizations and deaths. However, many were only deployed after the first epidemic wave, after key therapeutic interventions had been discovered, and only shortly before vaccine rollouts began. The digital tools were not available when they could have had maximal impact.
"With some 'peacetime' investment, digital contact tracing apps could be ready to play a key, low-cost role in mitigating infectious disease transmission from day one of a future outbreak."
Preparing for the next pandemic
The Oxford Martin School team held an international workshop in September which brought together interdisciplinary experts to reflect on lessons from COVID-19 and to discern the current research and investment gaps which are limiting our digital pandemic preparedness. This community of researchers is now calling for public health agencies to invest in digital public health technology before the next infectious disease emergency, proposing three key requirements:
- Day one readiness. The majority of the design work and testing of digital tools should take place between emergencies rather than in the midst of an outbreak, with expert input from behavioral science, ethics, technology, public health and epidemiology, and engagement with relevant publics, particularly communities at risk of exclusion or disproportionate harm. Platform approaches which can be quickly tailored to the pathogen and setting would enable gaps and solutions to be identified rapidly in a crisis, and peacetime use cases would keep the technology warm and ready to scale up in an emergency.
- Public health integration. Digital tools need to be integrated by public health agencies into their wider 'toolkit' of outbreak response, and regularly updated in line with the changing dynamics of an outbreak and developments in our understanding of symptoms and risk factors.
- Autonomy-preserving data and analytics. Digital tools should collect data in a way that preserves the privacy of users and is acceptable to the public, while providing public health agencies with sufficient and relevant data. Processes for the collection, storage, analysis and reporting of data should be confirmed now, ahead of the next outbreak.
More information
Michelle Kendall et al., Digital pandemic preparedness: key principles and requirements, building on lessons from COVID-19, Zenodo (2026). DOI: 10.5281/zenodo.24010105
Who's behind this story?
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Researchers urge significant 'peacetime' investment in contact tracing apps and digital public health tools (2026, November 19) retrieved 19 November 2026 from https://medicalxpress.com/news/2026-11-urge-significant-peacetime-investment-contact.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com